[1]
Palmer, A., Roze, S., Valentine, W. and Ray, J. 2006. Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland. Swiss Medical Weekly. 136, 2122 (May 2006), 346–346. DOI:https://doi.org/10.57187/smw.2006.11337.